Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 1, Pages 191
Publisher
MDPI AG
Online
2020-01-13
DOI
10.3390/cancers12010191
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges
- (2019) Corinne Frere et al. Cancers
- Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
- (2019) Robert Frank Cornell et al. Frontiers in Oncology
- Apixaban for the prevention of thromboembolism in Immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study
- (2019) Brigitte Pegourie et al. AMERICAN JOURNAL OF HEMATOLOGY
- The challenge of myeloma-related thromboembolic disease: can thrombin generation assay help physicians to better predict the thromboembolic risk and personalize anti-thrombotic prophylaxis?
- (2019) Yesim Dargaud et al. LEUKEMIA & LYMPHOMA
- Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants
- (2019) Maria Cristina Vedovati et al. THROMBOSIS RESEARCH
- Updates on thrombotic events associated with multiple myeloma
- (2019) Despina Fotiou et al. Expert Review of Hematology
- Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug–Associated Thrombosis Among Patients With Multiple Myeloma
- (2019) Ang Li et al. Journal of the National Comprehensive Cancer Network
- Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
- (2019) Kristen M. Sanfilippo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide- and lenalidomide-containing regimens
- (2018) Neill P. F. Storrar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences
- (2018) Audrey Bellesoeur et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) in the phase III ASPIRE study
- (2018) Meletios Dimopoulos et al. Journal of Hematology & Oncology
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
- (2018) María-Victoria Mateos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug–drug interactions
- (2018) Hanno Riess et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
- (2018) Andrew Spencer et al. HAEMATOLOGICA
- Predictive ability of the khorana score for venous thromboembolism (VTE) in multiple myeloma (MM).
- (2018) Kristen Marie Sanfilippo et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of venous thromboembolism with increased mortality in patients with multiple myeloma.
- (2018) Martin W. Schoen et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study
- (2018) Konstantinos Syrigos et al. ONCOLOGIST
- Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations
- (2018) Dawn Swan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study
- (2018) Despina Fotiou et al. Blood Cancer Journal
- Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real-world evaluation
- (2018) Hailey A. Baker et al. Cancer Medicine
- Use of direct oral anticoagulants in patients on immunomodulatory agents
- (2017) L. Man et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia
- (2016) Nabin Khanal et al. AMERICAN JOURNAL OF HEMATOLOGY
- Plasma Thrombin Generation and Sensitivity to Activated Protein C Among Patients With Myeloma and Monoclonal Gammopathy of Undetermined Significance
- (2016) Maeve P. Crowley et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: Report of 5 cases and literature review
- (2016) Ming Sheng Lim et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
- (2016) Dominique Farge et al. LANCET ONCOLOGY
- Baseline and treatment-related changes in thrombin generation in patients with multiple myeloma
- (2016) Ing S. Tiong et al. LEUKEMIA & LYMPHOMA
- Thromboprophylaxis in multiple myeloma patients treated with lenalidomide – A systematic review
- (2016) Fatimah Al-Ani et al. THROMBOSIS RESEARCH
- A review of the venous thrombotic issues associated with multiple myeloma
- (2016) Despina Fotiou et al. Expert Review of Hematology
- Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma
- (2015) Heyu Huang et al. BLOOD COAGULATION & FIBRINOLYSIS
- Induction therapy alters plasma fibrin clot properties in multiple myeloma patients
- (2015) Anetta Undas et al. BLOOD COAGULATION & FIBRINOLYSIS
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
- (2015) Sagar Lonial et al. NEW ENGLAND JOURNAL OF MEDICINE
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study
- (2014) P. G. Richardson et al. BLOOD
- Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma
- (2014) S. K. Kumar et al. BLOOD
- Pomalidomide: A Review of Its Use in Patients with Recurrent Multiple Myeloma
- (2014) Lesley J. Scott DRUGS
- International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation
- (2014) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
- (2014) Shaji K Kumar et al. LANCET ONCOLOGY
- Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma
- (2014) M A Dimopoulos et al. LEUKEMIA
- Venous Thromboembolism in Multiple Myeloma
- (2014) Tommaso Za et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Inhibitory effects of bortezomib on platelet aggregation in patients with multiple myeloma
- (2014) Joanna Rupa-Matysek et al. THROMBOSIS RESEARCH
- Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
- (2014) M A Dimopoulos et al. Blood Cancer Journal
- Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens
- (2013) Tina Bagratuni et al. AMERICAN JOURNAL OF HEMATOLOGY
- Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myelome 2009-02
- (2013) X. Leleu et al. BLOOD
- Increased PAC-1 expression among patients with multiple myeloma on concurrent thalidomide and warfarin
- (2013) Wan Z. Abdullah et al. BLOOD COAGULATION & FIBRINOLYSIS
- Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myeloma
- (2013) Guillemette Fouquet et al. CANCER
- Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
- (2013) Jesus San Miguel et al. LANCET ONCOLOGY
- New Oral Anticoagulants and the Cancer Patient
- (2013) N. J. Short et al. ONCOLOGIST
- Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational study
- (2012) Rachel Rosovsky et al. BRITISH JOURNAL OF HAEMATOLOGY
- Thrombosis is associated with inferior survival in multiple myeloma
- (2012) S. Y. Kristinsson et al. HAEMATOLOGICA
- Thrombosis in multiple myeloma (MM)
- (2012) Cesarman-Maus Hematology
- Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma
- (2012) Marta Robak et al. MEDICAL ONCOLOGY
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
- (2012) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide
- (2011) A. Larocca et al. BLOOD
- Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis
- (2011) Elias J. Anaissie et al. CANCER
- Low Venous Thromboembolic Risk With Bortezomib in Multiple Myeloma and Potential Protective Effect With Thalidomide/Lenalidomide-based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination Regimens
- (2011) Maurizio Zangari et al. Clinical Lymphoma Myeloma & Leukemia
- Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
- (2011) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study
- (2011) Cihan Ay et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
- (2011) M A Dimopoulos et al. LEUKEMIA
- Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of Thrombosis
- (2011) Elena Zamagni et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Thrombosis in Multiple Myeloma
- (2011) S. Y. Kristinsson Hematology-American Society of Hematology Education Program
- Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
- (2010) J. A. Zonder et al. BLOOD
- Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin
- (2010) Michela Cini et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
- (2010) J. J. A. Auwerda et al. THROMBOSIS AND HAEMOSTASIS
- Anticoagulation in the Treatment of Established Venous Thromboembolism in Patients With Cancer
- (2009) Agnes Y.Y. Lee JOURNAL OF CLINICAL ONCOLOGY
- Venous Thromboembolism in the Hematologic Malignancies
- (2009) Anna Falanga et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes
- (2009) L. L. SWYSTUN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
- (2008) C. Ay et al. BLOOD
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
- Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens
- (2008) Adriana M.W. van Marion et al. LEUKEMIA RESEARCH
- In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide
- (2007) Anna D. Petropoulou et al. THROMBOSIS RESEARCH
- Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro
- (2007) Ferit Avcu et al. THROMBOSIS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started